In this episode of The Egg Whisperer Show, I’m joined by Trudy McKanna, Senior Field Medical Director at GRAIL, to talk about a groundbreaking new test called Galleri®. This multi-cancer early detection test can identify signals of more than 50 different types of cancer through a simple blood draw, often before symptoms appear. For anyone focused on protecting their long-term health, identifying possible cancers early, and for those who have done treatment and may be concerned about future cancer risk, this technology could be life-changing.
We talk about how the Galleri® test works, the science behind it, and what this means for cancer treatment and detection. Trudy also shares why early detection is so critical, how accurate the test is, and what healthcare providers and patients need to know about accessing this innovation.
Read the full show notes on Dr. Aimee's site (with a transcript). In this episode, we cover:
- What GRAIL’s Galleri® test is and how it works
- How early cancer detection offers more time and options for care, plus how it may help patients avoid chemo
- Why the test could revolutionize preventative care and cancer treatment plans
- What fertility specialists and patients should know about using Galleri® after Clomid usage
- How GRAIL is working to expand access and education around early detection